Tumor Necrosis Factor-α Reduces Ketamine- and Propofol-Induced Anesthesia Time in Rats

Authors:
  • TYTadanobu Yasuda
    Tadanobu Yasuda
  • STSatoshi Takahashi
    Satoshi Takahashi
  • AMAkitomo Matsuki
    Akitomo Matsuki

Abstract
Tumor necrosis factor-α (TNFα) is a crucial neuromodulator in the brain. TNFα is involved in many physiological events including pain response and sleep. However, the interactions between TNFα and anesthetics have not been elucidated yet. In the present study, we investigated the effects of four intracerebroventricular (ICV) doses (1, 10, and 100 pg, and 1 ng) and two intraperitoneal (IP) doses (10 and 100 ng) of TNFα on anesthesia time of ketamine (100 mg/kg IP) and propofol (80 mg/kg IP) in rats. All ICV doses of TNFα reduced anesthesia time of ketamine and propofol compared with the saline ICV group (ketamine control group, 45.4 ± 6.5 min; propofol control group, 43.5 ± 11.0 min). The maximum effect was obtained after the ICV injection of 10 pg of TNFα (76% and 54% of ketamine and propofol control groups, respectively). Anesthesia time of ketamine or propofol was also decreased by IP injection of TNFα in a dose-dependent manner. Injection of 100 ng of TNFα IP reduced anesthesia time of ketamine and propofol by 67% and 64% of each control group, respectively. These data show that TNFα can modulate the anesthesia time of IV anesthetics, suggesting that anesthetic requirements might be altered in the presence of cerebral or systemic inflammation.

This publication has 25 references indexed in Scilit: